Brazil Threatens to Break Roche's HIV/AIDS Drug Patent
The Brazilian government has been playing hardball with multinational drugmakers to bring down the cost of HIV/AIDS drugs. Last month, Merck and Bristol-Myers Squibb both conceded substantial discounts.
However, Roche has been sticking to its guns at the negotiating table, offering a 5-9% discount. The Brazilian health ministry, which last month negotiated a record 76% discount for...
Already a subscriber? Click here to login